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 2 
ABSTRACT 38 
The Nairoviridae family within the Bunyavirales order comprise tick-borne segmented negative 39 
sense RNA viruses that cause serious disease in a broad range of mammals, yet cause a 40 
latent and life-long infection of tick hosts. An important member of this family is Crimean-41 
Congo haemorrhagic fever virus (CCHFV), which is responsible for serious human disease 42 
that results in case-fatality rates of up to 30%, and which exhibits the most geographically-43 
broad distribution of any tick-borne virus. Here, we explored differences in the cellular 44 
response of both mammalian and tick cells to nairovirus infection using Hazara virus (HAZV), 45 
which is a close relative of CCHFV within the CCHFV serogroup. We showed HAZV infection 46 
of human-derived SW13 cells led to induction of apoptosis, evidenced by activation of cellular 47 
caspases 3, 7 and 9. This was followed by cleavage of the classical apoptosis marker poly 48 
ADP-ribose polymerase, as well as cellular genome fragmentation. In addition, we showed 49 
that the HAZV nucleocapsid (N) protein was abundantly cleaved by caspase 3 in these 50 
mammalian cells at a conserved DQVD motif exposed at the tip of its arm domain, and that 51 
cleaved HAZV-N was subsequently packaged into nascent virions. However, in stark contrast, 52 
we showed for the first time that nairovirus infection of cells of the tick vector failed to induce 53 
apoptosis, evidenced by undetectable levels of cleaved caspases, and lack of cleaved HAZV-54 
N. Our findings reveal that nairoviruses elicit diametrically-opposed cellular responses in 55 
mammalian and tick cells, which may influence the infection outcome in the respective hosts. 56 
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INTRODUCTION 58 
 The Bunyavirales order is comprised of over 400 named viruses that each possess a 59 
segmented negative or ambisense sense, single stranded RNA (-ssRNA) genome. The order 60 
is divided into nine families; Feraviridae, Fimoviridae, Hantaviridae, Jonviridae, Nairoviridae, 61 
Peribunyaviridae, Phasmaviridae, Phenuiviridae and Tospoviridae, and members are 62 
responsible for infection and disease across a broad range of hosts including insects, animals, 63 
plants and humans. The bunyavirales responsible for human disease are classified within the 64 
Nairoviridae, Hantaviridae, Phenuiviridae and Peribunyaviridae families, and include notable 65 
human pathogens such as Rift Valley fever virus (RVFV), Ngari virus, Hantaan virus and 66 
Crimean-Congo haemorrhagic fever virus (CCHFV), each of which has been reported to 67 
cause fatal hemorrhagic fevers in humans. Many bunyavirales members are emerging 68 
viruses, for which disease-prevention strategies do not exist. 69 
 Hazara virus (HAZV) is a nairovirus, and is classified in the same serogroup as CCHFV 70 
on the basis of its serological reactivity and nucleotide sequence [1]. CCHFV is the causative 71 
agent of Crimean-Congo haemorrhagic fever (CCHF), a human disease that generally has 72 
case fatality rates between 20-30%, although these can be significantly higher in specific 73 
outbreaks, with no effective approved treatment or vaccination options available [2]–[4]. These 74 
factors have led to the classification of CCHFV as a Hazard Group 4 pathogen, requiring the 75 
highest containment level 4 (CL-4) laboratories for its growth. Both HAZV and CCHFV are 76 
arboviruses that infect ticks of the genus Hyalomma, and are transmitted to mammalian hosts 77 
through a tick bite or contact with contaminated blood or tissue [5], [6]. Studies exploring 78 
infection of multiple mammalian species including rats, guinea pigs and donkeys showed 79 
infection with either HAZV or CCHFV resulted in successful viral replication but no clinical 80 
manifestation of disease. Despite the high fatality rate associated with CCHFV infection in 81 
humans, only interferon receptor knockout mice and infant mice showed fatal clinical 82 
symptoms following both CCHFV and HAZV infections, with both viruses showing similar 83 
disease progression [7], [8]. Due to the inability of HAZV to cause clinical disease in humans, 84 
it is classified as a Hazard Group 2 pathogen, which facilitates its use as a model for studying 85 
CCHFV without the need to work in Containment Level 4 laboratory conditions. 86 
 The HAZV and CCHFV genomes consist of three -ssRNA genome segments, termed 87 
small (S), medium (M) and large (L) according to their relative sizes. These minimally encode 88 
the nucleoprotein (N), viral glycoproteins (Gn and Gc) and the viral RNA dependent RNA 89 
polymerase (RdRp), respectively. A critical role of N in the nairovirus replication cycle is to 90 
bind newly generated RNA replication products forming ribonucleoprotein (RNP) complexes 91 
that represent the template for viral transcription and replication [9], [10]. In addition, N from 92 
several nairoviruses has been reported to possess DNA endonuclease activity [11], although 93 
the functional consequence of this ability remains unclear. Nairovirus N proteins also exhibit 94 
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extensive structural homology with the N protein of Lassa virus (LASV), a member of the bi-95 
segmented Arenaviridae family [12]. The demonstration that LASV N possesses potent RNA 96 
endonuclease activity and the ability to supress anti-viral innate immunity [13] raises the 97 
interesting possibility that such functions are also shared with the N proteins from the 98 
Nairoviridae family. 99 
 Apoptosis is a critical cell response that ensures maintenance of homeostasis in 100 
multicellular organisms. Also being involved in the cellular response to injury, it is mediated 101 
via the sequential activation of a family of cysteine proteases known as caspases [14]. 102 
Activation of caspases requires an initial intrinsic or extrinsic signal; extrinsic signals originate 103 
from the death receptors of the tumour necrosis factor family on the cell surface, whilst intrinsic 104 
activation is mediated by cytochrome C release from the mitochondria causing activation of 105 
the initiator caspase, caspase 3 [15], [16]. The final result of apoptosis activation is cell death 106 
via cleavage of host-proteins by the activated executioner caspases 7 and 9, therefore 107 
complex regulatory mechanisms exist to modulate the process [17]. In order to facilitate the 108 
completion of their replication cycles, many viruses have evolved strategies to both induce or 109 
conversely delay induction of apoptosis. These strategies are diverse, targeting multiple 110 
stages of both the extrinsic and intrinsic pathways. For viruses that delay apoptosis, examples 111 
include inhibition of the pro-apoptotic tumour-suppressor p53 by the DNA virus SV40 and the 112 
direct inhibition of effector caspases by baculovirus p35 protein, which following cleavage 113 
remains irreversibly bound to the active site of the caspase [18]. Conversely, for viruses that 114 
promote apoptosis, examples include the closely-related Bunyamwera virus (BUNV) via 115 
activation of interferon regulatory factor 3 (IRF-3) and its related signalling pathways, and 116 
Oropouche virus in response to viral protein expression [19], [20]. Despite activation of 117 
apoptosis, BUNV and La Crosse virus (LACV) also regulate the induction of apoptosis at the 118 
early stages of infection through expression of the non-structural protein of the S segment 119 
(NSs) [21]. Together these strategies demonstrate the extensive arsenal viruses employ to 120 
modulate the cellular response to support their replication and survival.  121 
 In this study, we show that HAZV infection induces apoptosis in mammalian cells, and 122 
that N acts as a substrate for caspase 3 cleavage within infected cells. We identify the site of 123 
this cleavage and uncover extensive differences in cleavage of HAZV-N between tick vector 124 
and mammalian host cells that could have implications on how HAZV and, by association, 125 
CCHFV, are able to develop persistent infections in tick cells and modulate the mammalian 126 
apoptotic response [22]. 127 
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MATERIALS AND METHODS 129 
Viruses and cells. 130 
 Hazara virus, strain JC280 was propagated in SW13 cells (derived from human 131 
adrenal cortex) and maintained in Dulbecco’s modified Eagle medium (DMEM) (Sigma 132 
Aldrich) containing 10% fetal bovine serum (FBS) (Invitrogen), 100 U/mL penicillin and 100 133 
µg/mL streptomycin at 37°C in a 5% CO2 atmosphere. Tick-derived HAE/CTVM9 (Hyalomma 134 
anatolicum anatolicum) cells were maintained in L15 containing 20% FBS, 10% tryptose 135 
phosphate broth, 2 mM L-glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin at 30°C 136 
 137 
Transfection of protein encoding plasmids. 138 
 For expression of wild type HAZV-N and derived mutants, liposome-based 139 
transfections into SW13 cells were carried out according to the manufacturer’s instructions 140 
using 4 µL lipofectamine 2000 (Thermofisher) per µg of plasmid DNA. In all experiments, 1.5 141 
µg of plasmid DNA was used to transfect 105 cells. Cell lysates were harvested on ice using 142 
RIPA buffer (150 mM sodium chloride, 1.0% NP-40 alternative, 0.1% SDS, 50 mM Tris, pH 143 
8.0) at the indicated time points post transfection. 144 
 145 
Viral infection of mammalian and tick cells. 146 
 SW13 monolayers were infected with HAZV at the specified multiplicity of infection 147 
(MOI) in serum-free DMEM (SFM) at 37°C. After 1 hour, the inoculum was removed and cells 148 
washed in phosphate buffered saline (PBS), fresh DMEM containing 2.5% FBS, 100 U/mL 149 
penicillin and 100 µg/mL streptomycin was then applied for the duration of the infection. For 150 
comparison of HAZV infection and apoptosis induction in HAE/CTVM9 and SW13 cell lines, 151 
SW13 or HAE/CTVM9 cells were infected at an MOI of 0.001 in 25 cm2 flasks. Due to 152 
differences in cell behaviour, HAE/CTVM9 cells were infected in suspension and SW13 cells 153 
were infected as a monolayer at the respective culture conditions previously mentioned. In 154 
both cell types, virus was not removed following infection and flasks were returned to 155 
incubators for culture at their indicated temperatures. 156 
 157 
Virus purification. 158 
 HAZV was grown in SW13 cells and purified as previously described [23]. Briefly, 159 
SW13 cells were infected as described above and virus-containing media harvested 72 hours 160 
post infection. HAZV-containing media was then clarified via centrifugation at 4000 x g for 20 161 
minutes then HAZV particles were purified by pelleting through a 30% sucrose cushion, and 162 
then pellets were resuspended in PBS (pH 7.3) containing 0.5 mM MgCl2 and 20 mM CaCl2 163 
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and pooled. Purity of HAZV particles was assessed by PAGE, followed by Coomassie staining 164 
(data not shown) and western blotting with HAZV-N antiserum. 165 
 166 
Inhibition of caspase 3. 167 
 Z-FA-FMK (Santa Cruz Biotechnology) was selected to inhibit a broad spectrum of 168 
caspases. Z-FA-FMK was resuspended in DMSO to a concentration of 20 mM. Immediately 169 
prior to use, aliquots were thawed on ice and diluted in DMEM supplemented with 2.5% FBS 170 
to a working concentration of 20 µM or 40 µM. SW13 cells were seeded at 1 x 105 cells per 171 
well in a 12-well plate, 24 hours later cells were infected with HAZV at a MOI of 1 as described 172 
above. Following adsorption of HAZV to cell membranes, SFM containing HAZV was removed 173 
and replaced with DMEM containing 2.5% FBS and the indicated concentration of Z-FA-FMK. 174 
Whole cell lysates were harvested 24, 48 or 72 hours post-infection and analysed via western 175 
blot. 176 
 177 
Determination of cell viability. 178 
 MTT (2-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays were used 179 
to assess the cytotoxicity of Z-FA-ZMK treatments on SW13 cells. SW13 cells (1 x 104) were 180 
seeded in 96-well plates 24 hours prior to treatment with Z-FA-FMK. At 24, 48 or 72 hours 181 
after treatment, MTT assays were performed using the CellTiter96 non-radioactive cell 182 
proliferation assay kit (Promega), according to the manufacturer’s instruction. A dye solution 183 
containing MTT was added directly to the cells in 96 well plates, cells were incubated at 37°C 184 
for 4 hours, prior to addition of stop solution to solubilise the formazan product. Following 185 
overnight incubation, absorbance at 570 nm was recorded with the TECAN infinite F50 plate 186 
reader. Toxicity arising from DMSO at 0.1% or 0.2% dilutions was also compared; in both 187 
cases cell viability did not differ from untreated cells.  188 
 189 
Transient expression of viral proteins in mammalian cells. 190 
 pCAGGS-HAZV-N was used as the template for site directed mutagenesis. Generation 191 
of mutant HAZV-N (D272A) was achieved using the Q5 Site Directed Mutagenesis kit (New 192 
England Biolabs) according to the manufacturer’s instructions. The D272A mutant plasmid 193 
was validated via Sanger sequencing (GeneWiz). 194 
 195 
Bacterial expression and digestion of recombinant proteins. 196 
 Recombinant CCHFV and HAZV-N proteins were expressed in bacterial cells and 197 
purified as previously described [12], [24]. Recombinant caspase 3 was expressed from a 198 
plasmid encoding the full-length protein fused to a C-terminal 6×His tag (pET21b-Caspase-3, 199 
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Addgene). Briefly, protein expression was induced in E.coli strain Rosetta 2 using 200 μM 200 
isopropyl β-D-1-thiogalactopyranoside (IPTG) at 30 °C for 4 hours. Cells were harvested by 201 
centrifugation and proteins were extracted by resuspension in lysis buffer (50 mM Tris-HCl pH 202 
8, 100 mM NaCl, 1% Triton X-100, 1 mg/mL lysozyme (Sigma Aldrich), 1 unit (U) DNase and 203 
1 U RNase). Lysates were clarified by centrifugation at 18,000 x g for 30 min at 4 °C and the 204 
supernatant was applied to Ni2+-NTA resin pre-equilibrated in binding buffer (100 mM NaCl, 205 
50 mM Tris-HCl pH 8.0, 20 mM imidazole). The unbound fraction was collected and the resin 206 
was washed in binding buffer and washing buffer (500 mM NaCl, 50 mM Tris-HCl pH 8.0, 50 207 
mM imidazole). Elution buffer (100 mM NaCl, 50 mM Tris-HCl pH 8.0, 200 mM imidazole) was 208 
used to dissociate 6xHis-caspase 3 from the resin, and fractions containing purified caspase 209 
3 were pooled and concentrated to 1 mg/mL.  210 
 211 
Western blot analysis. 212 
 For preparation of cell lysates, monolayers were washed in ice cold PBS followed by 213 
incubation in ice cold RIPA buffer (150 mM sodium chloride, 1.0% NP-40 alternative, 0.1% 214 
SDS, 50 mM Tris, pH 8.0) and agitated for 120 seconds. Cells were then harvested via cell 215 
scraping and transferred to pre-chilled Eppendorf tubes, after which lysates were centrifuged 216 
at 20,000 x g for 15 minutes to pellet insoluble material. SDS-gel loading buffer containing 217 
DTT was added to the supernatant prior to storage at -20oC. Proteins were separated on 12% 218 
SDS polyacrylamide gels by electrophoresis and transferred to fluorescence compatible PVDF 219 
(FL-PVDF) membranes. Sheep HAZV-N antiserum generated as previously described [25] 220 
was used to detect HAZV-N, and was subsequently visualised using fluorescently labelled 221 
anti-sheep secondary antibodies. For the detection of cellular markers of apoptosis, 222 
membranes were probed with primary antibodies against caspase 3, 7, 9 and poly ADP-ribose 223 
polymerase  (PARP; Cell Signalling Technologies), and their respective cleaved forms (Cell 224 
Signalling Technologies) prior to the addition of the appropriate secondary antibodies. 225 
Membranes were visualised on the LiCor Odyssey Sa Infrared imaging system. 226 
 227 
TUNEL assay. 228 
 Apoptosis and subsequent DNA fragmentation was detected with an In-Situ Cell Death 229 
Detection Kit, Fluorescein (Roche) according to the manufacturer’s instructions. SW13 cells 230 
were seeded onto glass coverslips in 6 well plates 24 hours pre-infection, after which cells 231 
were infected with HAZV at a MOI of 1, or mock infected. Cells were fixed in 4% 232 
paraformaldehyde (PFA) at 24, 48 or 72 hours post-infection, and then permeabilised in 0.1%  233 
Triton-X 100 diluted in 0.1% sodium citrate for 5 minutes on ice. DNA strand breaks were then 234 
identified by labelling free 3’-OH DNA ends using the In-Situ Death Detection Kit, Fluorescein 235 
(Roche), in which the enzyme terminal deoxynucleotidyl transferase (TdT) catalyzed the 236 
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addition of fluorescently labelled nucleotides to free 3’-OH ends of cleaved DNA in a template 237 
independent manner. Cells were incubated with the enzyme reaction mix for 1 hour at 37oC. 238 
Fluorescein labelled nucleotides incorporated into nucleotide polymers were detected by 239 
fluorescence microscopy using the upright LSM 510 META confocal microscope (Carl Zeiss 240 
Ltd). 241 
  242 
 9 
Results 243 
HAZV induces apoptosis in mammalian cells. 244 
 The induction of apoptosis in mammalian cells has previously been described for the 245 
highly pathogenic nairovirus CCHFV, via both intrinsic and extrinsic pathways, and which was 246 
reported to be mediated by the CCHFV-NSs protein [26]. In order to determine whether the 247 
closely related HAZV also induced apoptosis in the mammalian SW13 cell line, SW13 cells 248 
were infected with HAZV at an MOI of 1 alongside a mock infected control. At 24, 48 and 72 249 
hours post infection, cell lysates were harvested and analysed for the presence of native 250 
caspase 3, 7, 9 and PARP, as well as the corresponding cleaved forms that represent markers 251 
of apoptosis induction (Fig 1A). All full-length caspases and PARP were detected with similar 252 
abundance in both mock and HAZV-infected cell lysates at all time points tested, whereas 253 
cleaved forms of caspase 3, 7, 9 and PARP were detected in robust abundance at both 48 254 
and 72 hours post infection in HAZV infected cells, indicative of apoptosis induction. In 255 
contrast, the cleaved forms were either undetectable or present at very low levels within mock 256 
infected cell cultures at all time points tested, indicating caspase cleavage and apoptosis was 257 
an infection-mediated response. 258 
 Alongside cleavage of caspases and their targets, we examined the effect of HAZV 259 
infection on an alternate marker of apoptosis, DNA fragmentation, via terminal dUTP nick end 260 
labelling (TUNEL) assay (Fig 1B). The TUNEL assay involves the enzymatic attachment of 261 
fluorescently labelled nucleotides to exposed 3’ hydroxyl groups, that are abundant when the 262 
DNA is fragmented [27], resulting in increased punctate fluorescence that can be observed by 263 
fluorescence microscopy. Consistent with caspase induction (Fig 1A), HAZV infection of 264 
SW13 cells at both 48 and 72 hours post infection resulted in an increased abundance of 265 
punctate fluorescence (Fig 1B). Quantification at the 72-hour time point revealed 266 
approximately 20% of cells displayed DNA fragmentation versus less than 5% in mock 267 
infected cells. Taken together, these data show HAZV triggers apoptosis in mammalian cells 268 
at an early time point, after 24 hrs but before 48 hours post infection. 269 
 270 
HAZV-N is cleaved in mammalian cells. 271 
 Previously, we and others have shown that nairoviruses possess conserved caspase 272 
cleavage sites within their respective N proteins [11], [12]. The N protein of CCHFV possesses 273 
an exposed DEVD motif that is recognised by caspase 3, and which has been suggested to 274 
be cleaved in a pro-cellular response, preserving cell viability and modulating infection. In 275 
addition, the presence of multiple caspase cleavage sites on the Junin arenavirus N protein 276 
was shown to delay apoptosis, possibly by acting as a substrate ‘sink’ to divert caspase-277 
activation of downstream effectors [28]. 278 
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 The HAZV-N protein possesses a conserved DQVD motif in precise structural 279 
alignment with the DEVD sequence of the CCHFV N protein, which represents a potential 280 
substrate for cleavage by several caspases. Having established that HAZV infection of SW13 281 
mammalian cells induces a robust apoptotic response, we next examined the interplay 282 
between apoptosis, activated caspases and the conserved DQVD motif within the HAZV-N 283 
protein during infection. 284 
 The expression and integrity of HAZV-N was investigated in SW13 cells following 285 
infection with HAZV at 24, 48 and 72 hour time points post infection by western blot analysis 286 
using HAZV-N antisera (Fig 2A). Multiple HAZV-N specific bands were observed at all time 287 
points tested and comprised full length HAZV-N at »54 kDa, as well as cleavage products at 288 
»45 kDa, »30 kDa and »20 kDa. At the 24 hour time point, bands representing full-length and 289 
45 kDa N-specific forms were most abundant, whereas at the later 48 and 72 hour time points, 290 
bands corresponding to »30 kDa and »20 kDa forms were more readily detected. To determine 291 
whether these cleavage products were incorporated into virions, purified HAZV was analysed 292 
via western blotting for HAZV-N specific products (Fig 2B), which revealed both »30 kDa and 293 
»20 kDa cleaved forms were present, alongside multiple N-specific forms with molecular 294 
masses in the 45 kDa range. To predict the corresponding sites of possible cleavage, we 295 
utilised the GraBCas programme, which predicts recognition sites for caspases 1–9 and 296 
granzyme B within any given amino acid sequence. This resulted in the identification of 297 
potential cleavage motifs, 57NERD60, 248DVMD251 and 269DQVD272 (Fig 2C). Utilising the 298 
Expasy prediction tool, cleavage at the 269DQVD272 site would generate products with 299 
estimated molecular masses of 30.7 kDa and 23.5 kDa, closely matching the products 300 
observed via western blot analysis (Fig 2A and B). In order to visualise the location of the 301 
cleavage site, the 269DQVD272 motif is shown in relation to the 3D structural model and 2D 302 
schematic of HAZV-N (Fig 2D and E). 303 
 304 
HAZV-N cleavage is abrogated by broad spectrum caspase inhibition. 305 
 To confirm the N protein cleavage products detected in cells (Fig 2) were caspase 306 
dependant, HAZV-infected SW13 cells were treated with the broad-spectrum caspase inhibitor 307 
Z-FA-FMK at concentrations of 20 µM or 40 µM, or cells were treated with DMSO as a control. 308 
Z-FA-FMK is an irreversible cysteine protease inhibitor that resembles the cleavage sites of 309 
known caspase substrates, functioning via alkylation of the critical cysteine residues in the 310 
caspase active site [29]. Western blot analysis of inhibitor treated cell lysates revealed a 311 
dramatic reduction in abundance of the »20 kDa HAZV-N fragment versus DMSO only controls 312 
(Fig 3A-C), indicating Z-FA-FMK treatment blocked N cleavage, and thus implicating the 313 
cleavage event as being caspase dependent. To rule out any effects on cell viability by Z-FA-314 
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FMK, an MTT assay was performed (Fig 3D). Whilst cell viability levels were approximately 315 
80% when treated with inhibitor versus the DMSO controls, there was no significant difference 316 
between the 20 µM or 40 µM doses, indicating the small effect on viability was not dose-317 
dependent. 318 
 319 
Mutations to the DQVD motif of HAZV-N prevent cleavage. 320 
 Having shown that HAZV-N within infected SW13 cells was cleaved by caspases to 321 
yield prominent »20 kDa and »30 kDa fragments, we next wanted to precisely identify the 322 
cleavage site. The DQVD (269-272) sequence within HAZV-N is located at a structurally 323 
identical site to the confirmed DEVD caspase 3 cleavage motif of CCHFV-N, strongly 324 
implicating this sequence as the target for cleavage. In addition, as mentioned above, 325 
cleavage at this DQVD site was predicted to yield the observed » 20 kDa and » 30 kDa species 326 
(Fig 2A). 327 
 To investigate whether the DQVD motif was the site of caspase cleavage, both wild-328 
type (WT) and D272A forms of HAZV-N were transiently expressed from plasmids in SW13 329 
cells undergoing apoptosis. The HAZV-N DQVD motif was modified by alanine substitution of 330 
the essential terminal D272 to generate an uncleavable DQVA sequence (HAZV-N-D272A). 331 
Cells expressing either HAZV-N or HAZV-N-D272A were treated at 24 hours post transfection 332 
with 1 µM staurosporine (STS) for 4 hours to induce apoptosis, after which cell lysates were 333 
collected and analyzed by western blot. As expected, transient expression of WT and mutant 334 
HAZV-N in all cells resulted in abundant detection of the 54 kDa full-length N (Fig 4A, blot 335 
panel 1). The presence of full-length caspase 3 was detected in all cell lysates (Fig 4A, blot 336 
panel 2), with cleaved caspase 3 only present in staurosporine treated cells (Fig 4A, blot panel 337 
3), indicating that STS treatment has successfully triggered the induction of apoptosis. 338 
Crucially, in these apoptotic cells, the »20 kDa and »30 kDa cleaved forms of N were detected 339 
in cells expressing WT HAZV-N (Fig 4A, blot 4 and 5), and were almost undetectable in cells 340 
expressing mutant HAZV-N D272A (Fig 4A). Taken together these observations indicate 341 
cleavage at the DQVD site results in the observed HAZV-N-specific »20 kDa and »30 kDa 342 
products. 343 
 In this STS experiment, we used the detection of caspase 3 and its cleaved derivative 344 
solely as a marker for apoptosis induction. However, we previously demonstrated that 345 
CCHFV-N is a substrate for caspase 3 resulting in cleavage at its DEVD motif (Fig 4B), and 346 
work by others has shown that HAZV-N can also be cleaved by caspase 3, to apparently yield 347 
multiple products in the 20-30 kDa range [11]. To clarify the origin of these species, we next 348 
wanted to examine the caspase 3 cleavage profile of HAZV-N and confirm the identity of the 349 
resulting products by western blotting using HAZV-N antisera. 350 
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 Recombinant bacterially-expressed CCHFV-N and HAZV-N proteins were incubated 351 
overnight with bacterially-expressed caspase 3 in either equimolar 1:1, or 2:1 ratios of caspase 352 
3 to HAZV-N (Fig 4C and D). The resulting products of digestion were separated by SDS-353 
PAGE and identified by western blotting using HAZV or CCHFV antisera, respectively, as well 354 
as cleaved caspase 3 antisera to confirm expression of the active protease. Caspase 3-355 
mediated cleavage of both nairovirus N proteins was incomplete, with abundant full-length 356 
protein remaining, and the proportions of full-length and cleaved forms of HAZV-N were 357 
broadly similar. The HAZV-N blots revealed the presence of two prominent N protein cleavage 358 
products having approximate molecular masses of »20 kDa and »30 kDa, which corresponded 359 
precisely to the apparent masses of the HAZN-N products identified in apoptotic SW13 cells 360 
(Fig 2A). Taken together, these data show the »20 kDa and »30 kDa fragments seen in HAZV 361 
infected cells are caspase 3 generated.  362 
 363 
Apoptosis and cleavage of HAZV-N is not observed in tick cells. 364 
 Nairoviruses such as CCHFV and HAZV are arboviruses that persist in life-long latent 365 
infections of their Hyalomma tick host, which contrasts sharply with the acute outcome of 366 
infection in human hosts, and is indicative of radically different host-pathogen interactions in 367 
these different cellular environments. In order to further explore these differences, HAZV 368 
infection of the tick cell line, HAE/CTVM9 was examined for its ability to support virus 369 
replication and induce apoptosis, as previously shown in SW13 cells (Fig 1A and B). Tick cells 370 
and SW13 cells were infected with HAZV and cell lysates were examined for expression of 371 
HAZV-N (Fig 5A and B) caspases 3, 7 and 9, as well as PARP in both their native and cleaved 372 
forms, 24, 48, 72 and 96 hours after infection by western blot analysis (Fig 5C). As with the 373 
mammalian SW13 cell line, initiator, executioner, or executioner targets (PARP) were 374 
abundantly expressed in tick cells at all time points. However, in stark contrast, the cleaved 375 
derivatives of all caspases and PARP were not detected, indicating that apoptosis was not 376 
induced in the tick-derived HAE/CTVM9 cell line at the time points tested. 377 
 Consistent with this finding, and the identification of the DQVD caspase 3 cleavage 378 
site in HAZV-N (Fig 4), the »20 kDa and »30 kDa caspase cleavage products of HAZV-N were 379 
either absent or detected in very low abundance in the HAE/CTVM9 cells (Fig 5B) indicating 380 
that HAZV-N remains mostly uncleaved in tick cells. These findings emphasize the differences 381 
between arthropod and mammalian cellular environments that are characterized by 382 
significantly different processing of virally encoded proteins. 383 
  384 
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DISCUSSION 385 
The life-cycle of HAZV and CCHFV nairoviruses exists in an enzootic cycle between 
ticks of the Hyalomma genus and mammals, yet despite discovery of CCHFV in 1944, little is 
known about the life-cycle of nairoviruses in cells of the natural tick host [30]. Current 
understanding suggests these viruses are able to form persistent, life-long infections, with no 
apparent detrimental effects on the tick vector, compared to transient and acute infections in 
their mammalian hosts [31] suggesting radical differences in these respective host-pathogen 
interactions. 
 Here we revealed one such difference, which is the ability of HAZV to induce apoptosis 
with the subsequent cleavage of HAZV-N in mammalian cells, in stark contrast to the lack of 
apoptosis induction and N cleavage in tick cells. The closely related CCHFV has previously 
been shown to induce apoptosis in mammalian cells at 18 hours post infection, via significant 
increases in mitochondrial associated apoptotic mediators such as BAX and XBP1s, with the 
response increasing through 24 and 48 hours [32]. This induction was subsequently shown to 
be stimulated through expression of a possible NSs accessory protein expressed by 
ambisense transcription from a second open reading frame (ORF) within the S segment. Here, 
we showed that HAZV infection of human SW13 cells led to induction of apoptosis between 
24-48 hours, suggesting this cellular response is a consistent feature of nairovirus 
multiplication in mammalian cells. Whether HAZV induces apoptosis by a functionally 
analogous S segment encoded protein is not yet known, although a second ORF does exist 
in a similar location to the NSs ORF of CCHFV [33]. In the case of CCHFV replication, the use 
of caspase inhibitors to block apoptosis induction resulted in a modest increase in virus titres, 
leading to the suggestion that apoptosis was a pro-cellular response that resulted in the 
restriction of virus growth. This suggestion raises several interesting questions, such as why 
does CCHFV express a pro-apoptotic protein that subsequently reduces virus titres, and 
clearly more work remains to be done to resolve these fundamental questions. One possibility 
is that the function of innate immune regulating components, such as the above mentioned 
NSs protein, is confined to one or other of the natural hosts, rather than both, by differential 
ability to interact with a respective host factor. Our observation that HAZV infection of tick cells 
in culture does not induce apoptosis may directly relate to the ability of the virus to establish 
persistent infections in the tick host. It could be that HAZV possesses the ability to delay or 
prevent apoptosis induction in the tick cell, but may be ineffective in preventing apoptosis 
induction in mammalian cells due to differences in effector host components. 
 La Crosse virus (LACV), for example, is another arbovirus of the Bunyavirales order, 
which infects both mammalian and insect hosts, however the outcome of these infections are 
extremely different; whilst mammalian cells display extensive cytopathic effects as a result of 
the inhibition of the anti-apoptotic properties of heat shock chaperone 70 [34], infection in 
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mosquito cells is not cytopathic and leads to persistence [35]. This difference in infection 
outcome in vector and host cells is also mirrored in BUNV infections, where cytopathic effects 
are detectable by 36 hours post infection in mammalian cell lines, whereas persistent, non-
cytopathic infections are established in mosquito cells [36]. 
 A further interesting aspect of nairovirus apoptosis induction is the cleavage of the N 
protein, which we previously showed occurred in vitro at a conserved site on the exposed tip 
of the CCHFV-N arm domain [12]. Here we show a similar caspase cleavage event occurs at 
the equivalent site on HAZV-N during mammalian cell infection. 
 It remains to be determined what role the cleavage of HAZV-N by cellular caspases 
might play in the replication cycle of HAZV. In the case of influenza virus, caspase cleavage 
of its functionally analogous N appears to be required for infection, as evidenced by the finding 
that viruses bearing caspase site alterations cannot be rescued into infectious viruses [37]. In 
the case of Junin arenavirus (JUNV), the functionally-analogous N protein possesses multiple 
caspase cleavage sites that are thought to act as decoy caspase 3 substrates, thereby 
interfering with activation of downstream executioner caspases, and delaying apoptosis 
induction [28]. This conclusion is consistent with the high conservation of these JUNV caspase 
recognition motifs, which interestingly, is also a feature of the nairovirus N. In the face of the 
high mutation rate of RNA viruses, we believe the conservation of these cleavage sites is 
highly suggestive of a pro-viral role, although what this role might be is currently unknown. 
Previous work has shown that alteration of the caspase cleavage site in CCHFV-N increases 
RNA synthesis, indicating the role of this cleavage may be at an alternative stage of the virus 
life-cycle [38]. It is also worth noting that the cleavage site of HAZV-N lies at the critical 
interface between monomers when they are in an oligomerised state, and alterations to this 
motif may have structural impacts in addition to loss of the cleavage site [24]. In contrast to 
the outcome of infection in mammalian cells, we showed that HAZV infection in tick cells was 
not associated with substantial N cleavage. This is an important finding as it suggests that 
such cleavage events are not obligatory for completion of the many roles of N in the HAZV 
infectious cycle, such as RNP assembly, RNA synthesis, segment packaging and virion 
assembly. Further analysis of the role of the conserved DQVD motif, and N caspase cleavage 
will be facilitated by the development of a reverse genetics system for HAZV, to complement 
the system already available for CCHFV. 
 
ACKNOWLEDGEMENTS 
The authors would like to thank Dr Bell-Sakyi and the Tick Cell Biobank, University of Liverpool 
for kindly providing HAE/CTVM9 cells. 
  
 15 
AUTHOR CONTRIBUTIONS 
Author contributions are as follows: JF, RAS, ABS, BA-R, GS, RH and JNB conceptualized 
the study; JF, RAS, ABS, BA-R, GS performed the experimental investigation; JF, RAS and 
JNB wrote the original draft manuscript; ABS, BA-R, GS reviewed and edited the manuscript; 
TAE, RH and JNB supervised the core team; JNB provided management and coordination of 
the research activities and acquired the financial support for the project. 
 
CONFLICTS OF INTEREST 
The author(s) declare that there are no conflicts of interest 
 
FUNDING 
This work was funded by a Public Health England (PHE) PhD studentship (to J. Fuller), 
EU Marie Skłodowska-Curie Actions (MSCA) Innovative Training Networks (ITN): H2020-
MSCA-ITN-2016, grant agreement No 721367 (to B. Álvarez-Rodríguez) and Biotechnology 
and Biological Sciences Research Council (BBSRC) PhD studentship to A. B. Shaw.  
 
REFERENCES  
[1] L. Lasecka and M. D. Baron, “The molecular biology of nairoviruses, an emerging 
group of tick-borne arboviruses,” Arch. Virol., vol. 159, no. 6, pp. 1249–1265, 2014. 
[2] S. K. Al-Tikriti, F. Al-Ani, F. J. Jurji, H. Tantawi, M. Al-Moslih, N. Al-Janabi, M. I. 
Mahmud, A. Al-Bana, H. Habib, H. Al-Munthri, S. Al-Janabi, K. AL-Jawahry, M. 
Yonan, F. Hassan, and D. I. Simpson, “Congo/Crimean haemorrhagic fever in Iraq,” 
Bull. World Health Organ., vol. 59, no. 1, pp. 85–90, 1981. 
[3] A. Papa, I. Christova, E. Papadimitriou, and A. Antoniadis, “Crimean-Congo 
hemorrhagic fever in Bulgaria,” Emerg. Infect. Dis., vol. 10, no. 8, pp. 1465–1467, 
2004. 
[4] P. Nabeth, D. O. Cheikh, B. Lo, O. Faye, I. O. M. Vall, M. Niang, B. Wague, D. Diop, 
M. Diallo, B. Diallo, O. M. Diop, and F. Simon, “Crimean-Congo hemorrhagic fever, 
Mauritania,” Emerg. Infect. Dis., vol. 10, no. 12, pp. 2143–2149, 2004. 
[5] F. Begum, C. L. Wisseman, and J. Casals, “Tick-borne viruses of west pakistan: II. 
Hazara virus, a new agent isolated from Ixodes redikorzeviticks from the Kaghan 
Valley, W. Pakistan,” Am. J. Epidemiol., vol. 92, no. 3, pp. 192–194, 1970. 
[6] T. G. Okorie, “Comparative studies on the vector capacity of the different stages of 
Amblyomma variegatum Fabricius and Hyalomma rufipes Koch for Congo virus, after 
intracoelomic inoculation,” Vet. Parasitol., vol. 38, no. 2–3, pp. 215–223, 1991. 
[7] S. E. Smirnova, “A comparative study of the Crimean hemorrhagic fever-Congo group 
of viruses,” Arch. Virol., vol. 62, no. 2, pp. 137–143, 1979. 
 16 
[8] S. D. Dowall, S. Findlay-Wilson, E. Rayner, G. Pearson, J. Pickersgill, A. Rule, N. 
Merredew, H. Smith, J. Chamberlain, and R. Hewson, “Hazara virus infection is lethal 
for adult type I interferon receptor-knockout mice and may act as a surrogate for 
infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus,” J. 
Gen. Virol., vol. 93, no. 3, pp. 560–564, 2012. 
[9] C. A. Whitehouse, “Crimean-Congo hemorrhagic fever,” Antiviral Res., vol. 64, no. 3, 
pp. 145–160, 2004. 
[10] S. Morikawa, M. Saijo, and I. Kurane, “Recent progress in molecular biology of 
Crimean-Congo hemorrhagic fever,” Comp. Immunol. Microbiol. Infect. Dis., vol. 30, 
no. 5–6, pp. 375–389, 2007. 
[11] W. Wang, X. Liu, X. Wang, H. Dong, C. Ma, J. Wang, B. Liu, Y. Mao, Y. Wang, T. Li, 
C. Yang, and Y. Guo, “Structural and Functional Diversity of Nairovirus-Encoded 
Nucleoproteins,” J. Virol., vol. 89, no. 23, pp. 11740–11749, 2015. 
[12] S. D. Carter, R. Surtees, C. T. Walter, A. Ariza, É. Bergeron, S. T. Nichol, J. A. 
Hiscox, T. A. Edwards, and J. N. Barr, “Structure, function, and evolution of the 
Crimean-Congo hemorrhagic fever virus nucleocapsid protein.,” J. Virol., vol. 86, no. 
20, pp. 10914–10923, 2012. 
[13] X. Qi, S. Lan, W. Wang, L. M. L. Schelde, H. Dong, G. D. Wallat, H. Ly, Y. Liang, and 
C. Dong, “Cap binding and immune evasion revealed by Lassa nucleoprotein 
structure,” Nature, vol. 468, no. 7325, pp. 779–783, 2010. 
[14] S. Elmore, “Apoptosis: A Review of Programmed Cell Death,” Toxicol. Pathol., vol. 35, 
no. 4, pp. 495–516, 2007. 
[15] A. Ashkenazi and V. M. Dixit, “Death receptors: signaling and modulation.,” Science, 
vol. 281, no. 5381, pp. 1305–1308, 1998. 
[16] P. K. Ho and C. J. Hawkins, “Mammalian initiator apoptotic caspases,” FEBS J., vol. 
272, no. 21, pp. 5436–5453, 2005. 
[17] B. J. Thomson, “Viruses and apoptosis,” Int. J. Exp. Pathol., vol. 82, no. 2, pp. 65–76, 
2001. 
[18] Q. Zhou, J. F. Krebs, S. J. Snipas, A. Price, E. S. Alnemri, K. J. Tomaselli, and G. S. 
Salvesen, “Interaction of the baculovirus anti-apoptotic protein p35 with caspases. 
Specificity, kinetics, and characterization of the caspase/p35 complex,” Biochemistry, 
vol. 37, no. 30, pp. 10757–10765, 1998. 
[19] A. Kohl, R. F. Clayton, F. Weber, A. Bridgen, R. E. Randall, and R. M. Elliott, 
“Bunyamwera Virus Nonstructural Protein NSs Counteracts Interferon Regulatory 
Factor 3-Mediated Induction of Early Cell Death,” J. Virol., vol. 77, no. 14, pp. 7999–
8008, 2003. 
[20] G. O. Acrani, R. Gomes, J. L. Proença-Módena, A. F. da Silva, P. Oliveira Carminati, 
 17 
M. L. Silva, R. I. M. Santos, and E. Arruda, “Apoptosis induced by Oropouche virus 
infection in HeLa cells is dependent on virus protein expression,” Virus Res., vol. 468, 
no. 7325, pp. 779–783, 2010. 
[21] G. Blakqori, S. Delhaye, M. Habjan, C. D. Blair, I. Sanchez-Vargas, K. E. Olson, G. 
Attarzadeh-Yazdi, R. Fragkoudis, A. Kohl, U. Kalinke, S. Weiss, T. Michiels, P. 
Staeheli, and F. Weber, “La Crosse Bunyavirus Nonstructural Protein NSs Serves To 
Suppress the Type I Interferon System of Mammalian Hosts,” J. Virol., vol. 81, no. 10, 
pp. 4991–4999, 2007. 
[22] L. Bell-Sakyi, “Continuous cell lines from the tick Hyalomma anatolicum anatolicum,” 
J. Parasitol., vol. 77, no. 6, pp. 1006–1008, 1991. 
[23] E. K. Punch, S. Hover, H. T. W. Blest, J. Fuller, R. Hewson, J. Fontana, J. Mankouri, 
and J. N. Barr, “Potassium is a trigger for conformational change in the fusion spike of 
an enveloped RNA virus,” J. Biol. Chem., vol. 293, no. 26, 2018. 
[24] R. Surtees, A. Ariza, E. K. Punch, C. H. Trinh, S. D. Dowall, R. Hewson, J. A. Hiscox, 
J. N. Barr, and T. A. Edwards, “The crystal structure of the Hazara virus nucleocapsid 
protein,” BMC Struct. Biol., vol. 15, p. 24, 2015. 
[25] R. Surtees, S. D. Dowall, A. Shaw, S. Armstrong, R. Hewson, M. W. Carroll, J. 
Mankouri, T. A. Edwards, J. A. Hiscox, and J. N. Barr, “Heat Shock Protein 70 Family 
Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus 
Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication 
Cycle,” J. Virol., vol. 90, no. 20, pp. 9305–9316, 2016. 
[26] B. Barnwal, H. Karlberg, A. Mirazimi, and Y.-J. Tan, “The Non-structural Protein of 
Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane 
Potential and Induces Apoptosis,” J. Biol. Chem., vol. 291, no. 2, pp. 582–592, 2016. 
[27] K. Kyrylkova, S. Kyryachenko, M. Leid, and C. Kioussi, “Detection of apoptosis by 
TUNEL assay.,” Methods Mol. Biol., vol. 887, pp. 41–47, 2012. 
[28] S. Wolff, S. Becker, and A. Groseth, “Cleavage of the Junin Virus Nucleoprotein 
Serves a Decoy Function To Inhibit the Induction of Apoptosis during Infection,” J. 
Virol., vol. 87, no. 1, pp. 224–233, 2013. 
[29] P. Schotte, W. Declercq, S. Van Huffel, P. Vandenabeele, and R. Beyaert, “Non-
specific effects of methyl ketone peptide inhibitors of caspases,” FEBS Lett., vol. 442, 
no. 1, pp. 117–121, 1999. 
[30] H. Hoogstraal, “The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in 
Asia, Europe, and Africa.,” J. Med. Entomol., vol. 15, no. 4, pp. 307–417, 1979. 
[31] A. Papa, K. Tsergouli, K. Tsioka, and A. Mirazimi, “Crimean-Congo Hemorrhagic 
Fever: Tick-Host-Virus Interactions,” Front. Cell. Infect. Microbiol., vol. 7, p. 213, 2017. 
[32] R. Rodrigues, G. Paranhos-Baccalà, G. Vernet, and C. N. Peyrefitte, “Crimean-Congo 
 18 
Hemorrhagic Fever Virus-Infected Hepatocytes Induce ER-Stress and Apoptosis 
Crosstalk,” PLoS One, vol. 7, no. 1, p. e29712, Jan. 2012. 
[33] R. Hewson, J. Chamberlain, V. Mioulet, G. Lloyd, B. Jamil, R. Hasan, A. Gmyl, L. 
Gmyl, S. E. Smirnova, A. Lukashev, G. Karganova, and C. Clegg, “Crimean-Congo 
haemorrhagic fever virus: Sequence analysis of the small RNA segments from a 
collection of viruses world wide,” Virus Res., vol. 102, no. 2, pp. 185–189, 2004. 
[34]  a Pekosz, J. Phillips, D. Pleasure, D. Merry, and F. Gonzalez-Scarano, “Induction of 
apoptosis by La Crosse virus infection and role of neuronal differentiation and human 
bcl-2 expression in its prevention.,” J. Virol., vol. 70, no. 8, pp. 5329–5335, 1996. 
[35] D. Hacker, R. Raju, and D. Kolakofsky, “La Crosse virus nucleocapsid protein controls 
its own synthesis in mosquito cells by encapsidating its mRNA.,” J. Virol., vol. 63, no. 
12, pp. 5166–5174, 1989. 
[36] S. E. Newton, N. J. Short, and L. Dalgarno, “Bunyamwera virus replication in cultured 
Aedes albopictus (mosquito) cells: establishment of a persistent viral infection.,” J. 
Virol., vol. 38, no. 3, pp. 1015–1024, 1981. 
[37] O. P. Zhirnov and V. V Syrtzev, “Influenza virus pathogenicity is determined by 
caspase cleavage motifs located in the viral proteins,” J Mol Genet Med, vol. 3, no. 1, 
pp. 124–132, 2009. 
[38] Y. Wang, S. Dutta, H. Karlberg, S. Devignot, F. Weber, Q. Hao, Y. J. Tan, A. Mirazimi, 
and M. Kotaka, “Structure of Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein: 
Superhelical Homo-Oligomers and the Role of Caspase-3 Cleavage,” J. Virol., vol. 86, 
no. 22, pp. 12294–12303, 2012. 
  
 19 
FIGURE LEGENDS 
Figure 1. HAZV induces apoptosis in mammalian cells, A) Activation of apoptosis-
associated caspases. SW13 cells were infected (Inf) with WT HAZV at a MOI of 1, alongside 
mock uninfected controls. At 24, 48 and 72 hours post infection lysates were collected and 
analysed via SDS-PAGE and western blotting using antibodies specific for the stated 
caspases (Casp), poly ADP-ribose polymerase (PARP), their cleaved forms (– C). Detection 
of GAPDH was used as a lysate loading control. B) Detection of dsDNA fragmentation 
associated with apoptosis. SW13 cells were infected with WT HAZV at an MOI of 1, alongside 
mock uninfected controls. At 24, 48 and 72 hours post infection, cells were visualized via 
confocal microscopy to identify nuclei displaying DNA fragmentation. Associated levels of 
TUNEL positive cells were determined relative to total cell number and displayed graphically 
(right).  
 
Figure 2. Cleavage of HAZV-N in mammalian cells, A) Detection of multiple HAZV-N 
products. SW13 cells were infected with WT HAZV at an MOI of 1, and after 48 h, cell lysates 
were collected and analysed via SDS-PAGE and western blotting. Four species reactive to 
HAZV-N antisera were detected; full length N at 54 kDa, and cleavage products at 45 kDa (*), 
30 kDa (**) and 20 kDa (***). Detection of GAPDH was used as a lysate loading control. B) 
Cleaved forms of HAZV-N were also detected in purified HAZV virions. C) Predicted caspase 
cleavage sites in HAZV-N determined by GraBCas prediction software, and the motifs with 
the three highest scores are displayed, with arrows indicating the site of cleavage. D) 
Representation of the predicted cleavage sites, NERD, DVMD and DQVD mapped onto the 
3D structural model of HAZV-N. E) Schematic linear representation of the HAZV S-segment 
displaying relative locations of the NERD, DVMD and DQVD cleavage sites. Numbers 
correspond to amino acid positions within the HAZV-N ORF, non-translated regions (NTRs) 
are also shown. 
 
Figure 3. Broad spectrum inhibition of caspases prevents HAZV-N cleavage. HAZV-N 
was progressively cleaved during the course of a 72 hour (hr) infection time course, with the 
≈ 20 kDa cleavage product undetectable at A) 24 hours, and detectable with increasing 
abundance at B) 48 and, C) 72 hours post-infection. Detection of GAPDH was used as a lysate 
loading control in all blots. Inhibition of broad spectrum caspases with 20 μM or 40 μM Z-FA-
FMK resulted in reduced detection of the ≈ 20 kDa band in comparison to the 0.1 and 0.2% 
DMSO controls. D) Cell viability in the presence of inhibitor and solvent was tested by treating 
cells with either 20 μM or 40 μM Z-FA-FMK, or cells 0.1% or 0.2% DMSO in triplicate. The 
graph represents an average of 3 independent absorbance readings. 
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Figure 4. The DQVD motif in HAZV-N is responsible for generation of cleavage products, 
and is cleaved by caspase 3. A) SW13 cells were transfected with either pCAGGS-HAZV-N 
or pCAGGS-HAZV-N(D272A) for 24 hours, then apoptosis was stimulated via treatment with 
1 μM staurosporine (STS) for 4 hours. At this time point, total cell lysates were collected and 
analyzed for caspase 3 (Casp 3) its activated cleaved form (Casp 3 – C) and HAZV-N 
cleavage products via western blot. Detection of GAPDH was used as a lysate loading control. 
B) Tabulation of similar cleavage sites in related orthonairoviruses HAZV, CCHFV, Erve virus 
(ERVEV) and Dugbe virus (DUGV). C) Recombinant CCHFV and, D) HAZV-N proteins were 
digested overnight with recombinant cleaved caspase 3, and N specific products were 
identified by western blot analysis using CCHFV-N and HAZV-N antisera, respectively, 
revealing the generation of major cleavage products with molecular masses of approximately 
20 and 30 kDa.  
 
Figure 5. Differential activation of apoptosis and HAZV-N cleavage in SW13 and 
HAE/CTVM9 cells. A) Monolayers of SW13 or B) HAE/CTVM9 cells were infected with an 
HAZV at an MOI of 0.001. At the indicated time points post-infection, total cell lysates were 
collected and analyzed for HAZV-N expression by western blotting with HAZV-N antisera. C) 
Expression and activation of caspases (Casp) was determined by infection of monolayers of 
SW13 or HAE/CTVM9 cells with HAZV. Following infection, total cell lysates were collected at 
the indicated time points and probed for specific full length and cleaved (- C) forms of 
caspases. Detection of GAPDH was used as a lysate loading control. Actin and GAPDH were 
detected as lysate loading controls. 
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Figure 3 
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